At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 20 enrolled
Drug / intervention
Curcumin +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Double-blind, Placebo-controlled Randomized Trial Phase II Evaluating the Effect of Curcumin for Treatment of Cancer Anorexia-Cachexia Syndrome in Patients With Stage III-IV of Head and Neck Cancer
Phramongkutklao College of Medicine and Hospital·interventional·Posted Dec 23, 2019·Updated Mar 28, 2023
In Brief
A Phase 2 clinical trial evaluating Curcumin and Placebo for Cancer Cachexia and 2 related conditions. Completed, enrolled 20 participants across 1 site.
Detailed Summary
A study of Curcumin to prevent cancer anorexia and cachexia Syndrom in locally advance and advance stage head and neck cancer (stage III, IV)
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesThailand
Collaborators--
Timeline
Phase 2CompletedFinished
2020202120222023202420252026
First PostedDec 2019
Enrollment StartFeb 2020
Primary CompletionFeb 2021
Study CompletionMar 2021
TodayJul 2026
First PostedDec 23, 2019
Enrollment StartFeb 13, 2020
Primary CompletionFeb 24, 2021
Study CompletionMar 31, 2021
TodayJul 2, 2026
Enrollment to primary: 1.0 yearsPosted 6.5 years ago
Interventions
Curcumindietary
We give an Intervention arm to consume Curcumin 4000mg/day for 60 consecutive days.
Placeboother
We give a control arm to consume placebo for 60 consecutive days.